Low-intensity focused ultrasound (LIFU) is gaining recognition beyond prenatal imaging, showing promise in drug delivery, cancer treatment, and psychiatric conditions. Biomedical engineer Elisa Konofagou discusses its development, emphasizing a historical context dating back to 1923, when early experiments demonstrated ultrasound's effects on biological tissues. LIFU offers a safe, cost-effective, and non-invasive approach that researchers are exploring for its potential to overcome significant medical challenges, particularly regarding the blood-brain barrier and other therapeutic areas. Konofagou's work facilitates clinical investigations that aim to translate these technologies into practical, real-world health solutions.
Researchers have turned to low-intensity focused ultrasound (LIFU) for its potential in treating various medical conditions, as it allows non-invasive drug delivery and tissue manipulation.
Elisa Konofagou notes the historical context, tracing the innovation in ultrasound technologies back to a 1923 study that highlighted its effects on biological tissues, opening doors for modern applications.
Collection
[
|
...
]